Psychosis
Disease3 papers1 finding
- Humans1
- Animals1
Effects
1SASP index
upin humans1
1 study
SASP index
upin humans1
Psychosis increases SASP index in humans.
Humansin early psychosis vs healthy controls
CSenescence-associated-secretory phenotype proteins and inflammatory pathways are involved in psychosis: A transdiagnostic study using the Human Connectome Project for early psychosis (HCP-EP) data · Brain, behavior, and immunity · 20 Sep 2026
Trial sponsors
1 trialPhase 424 people
National Taiwan University Hospital
1 trialPhase 420 people
Clinic for Psychiatric Disorders, Dr Laza Lazarevic
1 trialPhase 2/360 people
Pakistan Institute of Living and Learning
1 trialPhase 2326 people
New York State Psychiatric Institute
1 trialPhase 277 people
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
1 trialPhase 275 people
VA Greater Los Angeles Healthcare System
1 trialPhase 1/239 people
1 trialPhase 146 people
Funding
National Institute of Mental HealthUS$4.5mNational Institute on AgingUS$317.2k6 grants since 2022
PREMAP - Predictors and Risk Evaluation for Menopause-Associated Psychosis
National Institute of Mental HealthYale UniversityUS$415.1k2023–2027
Gene x Ovarian Hormone Interactions in Perimenopausal Risk for Psychosis
National Institute of Mental HealthMichigan State UniversityUS$796.1k2026–2031
Aberrant dopamine system function in a rodent model of perimenopause: relevance to psychosis
National Institute on AgingUniversity of Texas Hlth Science CenterUS$317.2k2023–2028
Multidimensional aging trajectories in mid to late-life psychosis (MAP)
National Institute of Mental HealthUniversity of Alabama at BirminghamUS$1.1m2023–2028
Hormonal Mechanisms of Perimenopausal Risk for Psychosis in Women
National Institute of Mental HealthMichigan State UniversityUS$680.7k2022–2027
National Institute of Mental HealthUniv of North Carolina Chapel HillUS$717.2k2022–2026
Latest
12Lewy body disease tracks with cognitive decline and psychosis
Lewy body disease prevalence rose from 0.7% in individuals younger than 50 to 20.0% in those aged 90 and older across 2,480 autopsied human brains.Lewy body disease prevalence rose from 0.7% in individuals younger than 50 to 20.0% in those aged 90 and older across 2,480 autopsied human brains.